Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore

BACKGROUND: Hepatitis C virus (HCV) infection is a major public health issue among people who inject drugs (PWID) with prevalence of 50–80% in the United States. Effective, simple, oral direct acting agents (DAA) of short duration with minimal side effects have been associated with cure rates > 9...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Subst Abuse Treat
Main Authors: Falade-Nwulia, Oluwaseun, Irvin, Risha, Merkow, Alana, Sulkowski, Mark, Niculescu, Alexander, Olsen, Yngvild, Stoller, Kenneth, Thomas, David L., Latkin, Carl, Mehta, Shruti H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545901/
https://ncbi.nlm.nih.gov/pubmed/30898327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2019.01.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados